International Clinical Trial: CAFs derived POSTN inhibits CD8 T cells to promote immune escape of breast cancer through CXCL12/CXCR4

Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125233) titled 'CAFs derived POSTN inhibits CD8 T cells to promote immune escape of breast cancer through CXCL12/CXCR4' on May 22.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: The First People's Hospital of Foshan

Condition: Breast cancer

Intervention: Healthy adults (Isolation, cultivation, and activation of CD8+T cells from peripheral blood of healthy adults):None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-05-22

Target Sample Size: Healthy adults (Isolation, cultivation, and activation of CD8+T cells from peripheral blood of healthy adults):12;Patien...